Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2026-03-04 @ 10:24 PM
Study NCT ID:
NCT03912961
Status:
COMPLETED
Last Update Posted:
2020-06-05
First Post:
2019-03-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Santa Cruz Diabetic Retinopathy Utilizing Artificial Intelligence Study
Sponsor:
Retina Global
Organization:
Study Overview
Official Title:
Comparative Analysis of Diabetic Retinopathy Images by Retina Specialists Versus EyeStar's Artificial Intelligence Software of Images Captured by Pictor Plus Retinal Camera
Status:
COMPLETED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SC-DRAI
Brief Summary:
In this clinical trial, we plan to evaluate the usefulness of artificial intelligence (AI) software paired with a handheld retinal camera to compare diabetic retinopathy status in Bolivian patients as read by retina specialists versus the AI software.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: